Ongoing measles transmission in under-vaccinated communities continues to drive U.S. case counts, with the CDC reporting 2,073 confirmed cases as of June 11, 2026—already approaching the full-year 2025 total of 2,288. Ninety-three percent of 2026 cases link to 30 outbreaks, predominantly among individuals unvaccinated or with unknown MMR status, reflecting sustained endemic circulation after the Americas lost elimination status in late 2025. Recent weekly additions of 40–60 cases underscore active chains in multiple states, though public health containment and seasonal patterns may moderate further growth before June 30. CDC’s weekly surveillance updates, including any new outbreak declarations or revised counts, represent the key near-term data releases that could shift trader-implied probabilities on final June totals.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoMeasles cases in U.S. by June 30?
Measles cases in U.S. by June 30?
$86,560 Wol.
Jun 30, 2026
2140
1%
2150
1%
2200
1%
2300
<1%
2400
<1%
$86,560 Wol.
2140
$3,958 Wol.
1%
2150
$32,276 Wol.
1%
2200
$27,847 Wol.
1%
2300
$9,745 Wol.
<1%
2400
$12,733 Wol.
<1%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in under-vaccinated communities continues to drive U.S. case counts, with the CDC reporting 2,073 confirmed cases as of June 11, 2026—already approaching the full-year 2025 total of 2,288. Ninety-three percent of 2026 cases link to 30 outbreaks, predominantly among individuals unvaccinated or with unknown MMR status, reflecting sustained endemic circulation after the Americas lost elimination status in late 2025. Recent weekly additions of 40–60 cases underscore active chains in multiple states, though public health containment and seasonal patterns may moderate further growth before June 30. CDC’s weekly surveillance updates, including any new outbreak declarations or revised counts, represent the key near-term data releases that could shift trader-implied probabilities on final June totals.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Rynek otwarty: May 28, 2026, 11:08 AM ET
Wolumen
$86,560Data zakończenia
Jun 30, 2026Rynek otwarty
May 28, 2026, 11:08 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in under-vaccinated communities continues to drive U.S. case counts, with the CDC reporting 2,073 confirmed cases as of June 11, 2026—already approaching the full-year 2025 total of 2,288. Ninety-three percent of 2026 cases link to 30 outbreaks, predominantly among individuals unvaccinated or with unknown MMR status, reflecting sustained endemic circulation after the Americas lost elimination status in late 2025. Recent weekly additions of 40–60 cases underscore active chains in multiple states, though public health containment and seasonal patterns may moderate further growth before June 30. CDC’s weekly surveillance updates, including any new outbreak declarations or revised counts, represent the key near-term data releases that could shift trader-implied probabilities on final June totals.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Wolumen
$86,560Data zakończenia
Jun 30, 2026Rynek otwarty
May 28, 2026, 11:08 AM ETResolver
0x65070BE91...Ongoing measles transmission in under-vaccinated communities continues to drive U.S. case counts, with the CDC reporting 2,073 confirmed cases as of June 11, 2026—already approaching the full-year 2025 total of 2,288. Ninety-three percent of 2026 cases link to 30 outbreaks, predominantly among individuals unvaccinated or with unknown MMR status, reflecting sustained endemic circulation after the Americas lost elimination status in late 2025. Recent weekly additions of 40–60 cases underscore active chains in multiple states, though public health containment and seasonal patterns may moderate further growth before June 30. CDC’s weekly surveillance updates, including any new outbreak declarations or revised counts, represent the key near-term data releases that could shift trader-implied probabilities on final June totals.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania